{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T12:54:31Z","timestamp":1784120071123,"version":"3.55.0"},"reference-count":199,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Pancreatic cancer is a highly aggressive malignancy with a 5-year relative survival rate of only 13%. Current treatment options have limited efficacy, and mRNA vaccines offer a new direction for its treatment. However, how to accurately identify antigen targets that possess tumor specificity, functional relevance, and immunogenicity remains the key bottleneck restricting the clinical translation of mRNA vaccines for pancreatic cancer. Recent clinical studies have advanced KRAS mutant vaccines and personalized neoantigen mRNA vaccines, yet most rely on single antigens or highly individualized designs, limiting scalability and broader clinical applicability. In this systematic review, we integrated evidence from public databases and experimental studies to identify and evaluate 16 potential pancreatic cancer mRNA vaccine antigens (ADAM9, WNT7A, TMOD3, MET, EFNB2, TPX2, AGPS, OSBPL9, KDM5A, NRAS, SCP-1, GAGE, RAB5A, ANO6, CHMP2B, and PAK2). All candidates were initially selected based on aberrant tumor expression and further prioritized using stratification strategies incorporating antigen-presenting cell infiltration, immune-related cell death pathways such as ferroptosis and pyroptosis, and functional relevance to tumor progression. ADAM9 and PAK2 showed high expression in pancreatic cancer and strong associations with tumor proliferation, invasion, and immune regulation. SCP-1 and GAGE, as cancer\u2013testis antigens, exhibited high tumor specificity and immunogenic potential. In addition, KDM5A and ANO6 may enhance antitumor efficacy through modulation of ferroptosis or pyroptosis. Nevertheless, several candidates remain constrained by normal tissue expression or limited mechanistic evidence. This review provides a stratified framework for antigen prioritization and highlights key challenges in pancreatic cancer mRNA vaccine development, offering guidance for future multi-antigen vaccine design and translational immunotherapy.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1803792","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T05:39:05Z","timestamp":1777354745000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of translational potential of mRNA vaccine candidate antigens for pancreatic cancer: a systematic review based on clinical evidence and stratified prioritization strategies"],"prefix":"10.3389","volume":"17","author":[{"given":"Yuzhe","family":"Xue","sequence":"first","affiliation":[{"name":"Jiaxing University Master Degree Cultivation Base, Zhejiang Chinese Medical University","place":["Hangzhou, Zhejiang, China"]},{"name":"Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Jiaxing University","place":["Jiaxing, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Yu","sequence":"additional","affiliation":[{"name":"Jiaxing University Master Degree Cultivation Base, Zhejiang Chinese Medical University","place":["Hangzhou, Zhejiang, China"]},{"name":"Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Jiaxing University","place":["Jiaxing, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongkun","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, The First Affiliated Hospital of Jiaxing University","place":["Jiaxing, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, The First Affiliated Hospital of Jiaxing University","place":["Jiaxing, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, The First Affiliated Hospital of Jiaxing University","place":["Jiaxing, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyu","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Jiaxing University","place":["Jiaxing, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runzhou","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Traditional Chinese Medical Hospital of Zhuji","place":["Zhuji, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjing","family":"Chen","sequence":"additional","affiliation":[{"name":"Jiaxing University Master Degree Cultivation Base, Zhejiang Chinese Medical University","place":["Hangzhou, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoguang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Jiaxing University","place":["Jiaxing, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuesong","family":"He","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Jiaxing University","place":["Jiaxing, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(23)00516-8","article-title":"Treatment of metastatic pancreatic cancer: 25 years of innovation with little progress for patients","volume":"25","author":"Gyawali","year":"2024","journal-title":"Lancet Oncol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.8664","article-title":"Impact of nationwide centralization of pancreaticoduodenectomy on hospital mortality","volume":"99","author":"de Wilde","year":"2012","journal-title":"Br J Surg"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdg207","article-title":"Adjuvant therapy in pancreatic cancer: historical and current perspectives","volume":"14","author":"Neoptolemos","year":"2003","journal-title":"Ann Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000267","article-title":"Preoperative\/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages","volume":"7","author":"Gillen","year":"2010","journal-title":"PloS Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-8-82","article-title":"Meta-analysis of randomized trials: evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer","volume":"8","author":"Heinemann","year":"2008","journal-title":"BMC Cancer"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdt239","article-title":"Neoadjuvant treatment of borderline resectable and non-resectable pancreatic cancer","volume":"24","author":"Heinemann","year":"2013","journal-title":"Ann Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2024.1575","article-title":"Perioperative modified FOLFIRINOX for resectable pancreatic cancer: a nonrandomized controlled trial","volume":"10","author":"Cecchini","year":"2024","journal-title":"JAMA Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.4512","article-title":"Modified FOLFIRINOX versus sequential chemotherapy (FOLFIRI\/FOLFOX) as a second-line treatment regimen for unresectable pancreatic cancer: a real-world analysis","volume":"11","author":"Tezuka","year":"2022","journal-title":"Cancer Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/504S16a","article-title":"Cancer vaccines: Material breach","volume":"504","author":"Dolgin","year":"2013","journal-title":"Nature"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2007.08.059","article-title":"Human papillomavirus vaccines and the potential for cross-protection between related HPV types","volume":"107","author":"Ault","year":"2007","journal-title":"Gynecol Oncol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12929-016-0293-9","article-title":"Perspectives for therapeutic HPV vaccine development","volume":"23","author":"Yang","year":"2016","journal-title":"J BioMed Sci"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol31090361","article-title":"Developing vaccines in pancreatic adenocarcinoma: trials and tribulations","volume":"31","author":"Phan","year":"2024","journal-title":"Curr Oncol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13025","article-title":"Peptide-based therapeutic cancer vaccine: current trends in clinical application","volume":"54","author":"Liu","year":"2021","journal-title":"Cell Prolif"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-11-291","article-title":"Phase I\/II clinical trial using HLA-A24-restricted peptide vaccine derived from KIF20A for patients with advanced pancreatic cancer","volume":"11","author":"Asahara","year":"2013","journal-title":"J Transl Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02804","article-title":"Current state of dendritic cell-based immunotherapy: opportunities for in vitro antigen loading of different DC subsets","volume":"9","author":"Huber","year":"2018","journal-title":"Front Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1200\/jco.23.02585","article-title":"Dendritic cell-based immunotherapy in patients with resected pancreatic cancer","volume":"42","author":"van 't Land","year":"2024","journal-title":"J Clin Oncol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1200\/jco.24.00846","article-title":"Future of dendritic cell-based approaches in pancreatic cancer","volume":"42","author":"Somasundaram","year":"2024","journal-title":"J Clin Oncol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-009765","article-title":"Dendritic cells pulsed with multifunctional Wilms' tumor 1 (WT1) peptides combined with multiagent chemotherapy modulate the tumor microenvironment and enable conversion surgery in pancreatic cancer","volume":"12","author":"Koido","year":"2024","journal-title":"J Immunother Cancer"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.1038\/s41467-021-22929-z","article-title":"Adjuvant oncolytic virotherapy for personalized anti-cancer vaccination","volume":"12","author":"Roy","year":"2021","journal-title":"Nat Commun"},{"key":"B20","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12943-021-01335-5","article-title":"mRNA vaccine for cancer immunotherapy","volume":"20","author":"Miao","year":"2021","journal-title":"Mol Cancer"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2019.01.020","article-title":"mRNA as a transformative technology for vaccine development to control infectious diseases","volume":"27","author":"Maruggi","year":"2019","journal-title":"Mol Ther"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-62703-260-5_8","article-title":"Programming human dendritic cells with mRNA","volume":"969","author":"Lee","year":"2013","journal-title":"Methods Mol Biol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(94)90336-0","article-title":"MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation","volume":"76","author":"Germain","year":"1994","journal-title":"Cell"},{"key":"B24","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s40779-022-00416-w","article-title":"Personalized pancreatic cancer therapy: from the perspective of mRNA vaccine","volume":"9","author":"Huang","year":"2022","journal-title":"Mil Med Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02760-3","article-title":"Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trial","volume":"30","author":"Pant","year":"2024","journal-title":"Nat Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-024-00990-9","article-title":"Combination therapy of KRAS G12V mRNA vaccine and pembrolizumab: clinical benefit in patients with advanced solid tumors","volume":"34","author":"Wang","year":"2024","journal-title":"Cell Res"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-025-01170-9","article-title":"Pancreatic cancer: advances in immunology, translational analyses and therapeutic paradigms","author":"O'Reilly","year":"2026","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-08508-4","article-title":"RNA neoantigen vaccines prime long-lived CD8(+) T cells in pancreatic cancer","volume":"639","author":"Sethna","year":"2025","journal-title":"Nature"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines - a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat Rev Drug Discov"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/nrd4278","article-title":"mRNA-based therapeutics--developing a new class of drugs","volume":"13","author":"Sahin","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat Rev Mater"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2018.04.001","article-title":"Immunotherapy and prevention of pancreatic cancer","volume":"4","author":"Morrison","year":"2018","journal-title":"Trends Cancer"},{"key":"B33","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.ccell.2020.08.004","article-title":"Challenges and opportunities for pancreatic cancer immunotherapy","volume":"38","author":"Bear","year":"2020","journal-title":"Cancer Cell"},{"key":"B34","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12943-021-01310-0","article-title":"Identification of tumor antigens and immune subtypes of pancreatic adenocarcinoma for mRNA vaccine development","volume":"20","author":"Huang","year":"2021","journal-title":"Mol Cancer"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e27194","article-title":"Discovering ferroptosis-associated tumor antigens and ferroptosis subtypes in pancreatic adenocarcinoma to facilitate mRNA vaccine development","volume":"10","author":"Yan","year":"2024","journal-title":"Heliyon"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.20006","article-title":"Expression of cancer testis antigens in pancreatic carcinoma cell lines, pancreatic adenocarcinoma and chronic pancreatitis","volume":"109","author":"Kubuschok","year":"2004","journal-title":"Int J Cancer"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12040726","article-title":"Identification of novel tumor pyroptosis-related antigens and pyroptosis subtypes for developing mRNA vaccines in pancreatic adenocarcinoma","volume":"12","author":"Lin","year":"2024","journal-title":"Biomedicines"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06063-y","article-title":"Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer","volume":"618","author":"Rojas","year":"2023","journal-title":"Nature"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2119662","article-title":"Neoantigen T-cell receptor gene therapy in pancreatic cancer","volume":"386","author":"Leidner","year":"2022","journal-title":"N Engl J Med"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/nrm1261","article-title":"Met, metastasis, motility and more","volume":"4","author":"Birchmeier","year":"2003","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.00055","article-title":"The function of the HGF\/c-Met axis in hepatocellular carcinoma","volume":"8","author":"Wang","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1205004","article-title":"Requirement of Stat3 signaling for HGF\/SF-Met mediated tumorigenesis","volume":"21","author":"Zhang","year":"2002","journal-title":"Oncogene"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0504367102","article-title":"Proliferation and invasion: plasticity in tumor cells","volume":"102","author":"Gao","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2025.2483379","article-title":"ITGA3-MET interaction promotes papillary thyroid cancer progression via ERK and PI3K\/AKT pathways","volume":"57","author":"Lan","year":"2025","journal-title":"Ann Med"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21239170","article-title":"Targeting HGF\/c-MET axis in pancreatic cancer","volume":"21","author":"Pothula","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B46","article-title":"Expression of the Met\/hepatocyte growth factor receptor in human pancreatic cancer","volume":"55","author":"Di Renzo","year":"1995","journal-title":"Cancer Res"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.200701086","article-title":"c-Met is essential for wound healing in the skin","volume":"177","author":"Chmielowiec","year":"2007","journal-title":"J Cell Biol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0165485","article-title":"The MET receptor tyrosine kinase confers repair of murine pancreatic acinar cells following acute and chronic injury","volume":"11","author":"Gaziova","year":"2016","journal-title":"PloS One"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1996.1789","article-title":"Ontogeny of hepatocyte growth factor and c-met\/hgf receptor in rat pancreas","volume":"229","author":"Calvo","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"key":"B50","article-title":"Expression of hepatocyte growth factor and c-met genes during hepatic differentiation and liver development in the rat","volume":"142","author":"Hu","year":"1993","journal-title":"Am J Pathol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1053\/j.gastro.2011.08.009","article-title":"c-Met is a marker of pancreatic cancer stem cells and therapeutic target","volume":"141","author":"Li","year":"2011","journal-title":"Gastroenterology"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-10-2527","article-title":"VEGF and c-Met blockade amplify angiogenesis inhibition in pancreatic islet cancer","volume":"71","author":"You","year":"2011","journal-title":"Cancer Res"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.Cd-11-0240","article-title":"Suppression of tumor invasion and metastasis by concurrent inhibition of c-Met and VEGF signaling in pancreatic neuroendocrine tumors","volume":"2","author":"Sennino","year":"2012","journal-title":"Cancer Discov"},{"key":"B54","article-title":"Coexpression of the c-met proto-oncogene and hepatocyte growth factor in human pancreatic cancer","volume":"54","author":"Ebert","year":"1994","journal-title":"Cancer Res"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1007\/DCR.0b013e3181bdca3a","article-title":"Cancer\/testis antigens and clinical risk factors for liver metastasis of colorectal cancer: a predictive panel","volume":"53","author":"Chen","year":"2010","journal-title":"Dis Colon Rectum"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.22141","article-title":"Cancer-testis antigen expression and its epigenetic modulation in acute myeloid leukemia","volume":"86","author":"Atanackovic","year":"2011","journal-title":"Am J Hematol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2011.10.008","article-title":"Cancer-testis and melanocyte-differentiation antigen expression in Malignant glioma and meningioma","volume":"19","author":"Syed","year":"2012","journal-title":"J Clin Neurosci"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.9.5211","article-title":"Identification of a meiosis-specific protein as a member of the class of cancer\/testis antigens","volume":"95","author":"T\u00fcreci","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2007.01.003","article-title":"Potential target antigens for immunotherapy in human pancreatic cancer","volume":"252","author":"Schmitz-Winnenthal","year":"2007","journal-title":"Cancer Lett"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-04-1487","article-title":"Identification of an epitope derived from the cancer testis antigen HOM-TES-14\/SCP1 and presented by dendritic cells to circulating CD4+ T cells","volume":"106","author":"Neumann","year":"2005","journal-title":"Blood"},{"key":"B61","article-title":"Characterization of the GAGE genes that are expressed in various human cancers and in normal testis","volume":"59","author":"De Backer","year":"1999","journal-title":"Cancer Res"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2006.11.022","article-title":"Expression of GAGE family proteins in Malignant melanoma","volume":"251","author":"Bazhin","year":"2007","journal-title":"Cancer Lett"},{"key":"B63","article-title":"Molecular detection of GAGE expression in peripheral blood and bone marrow: utility as a tumor marker for neuroblastoma","volume":"3","author":"Cheung","year":"1997","journal-title":"Clin Cancer Res"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.4103\/njcp.njcp_73_18","article-title":"Cancer-testis antigen GAGE-1 expression and serum immunoreactivity in hepatocellular carcinoma","volume":"21","author":"Chao","year":"2018","journal-title":"Niger J Clin Pract"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.21744","article-title":"Serological immune response to cancer testis antigens in patients with pancreatic cancer","volume":"119","author":"Wadle","year":"2006","journal-title":"Int J Cancer"},{"key":"B66","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12885-015-1998-y","article-title":"The role of GAGE cancer\/testis antigen in metastasis: the jury is still out","volume":"16","author":"Gjerstorff","year":"2016","journal-title":"BMC Cancer"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0045819","article-title":"GAGE cancer-germline antigens are recruited to the nuclear envelope by germ cell-less (GCL)","volume":"7","author":"Gjerstorff","year":"2012","journal-title":"PloS One"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109621","article-title":"GAGE mediates radio resistance in cervical cancers via the regulation of chromatin accessibility","volume":"36","author":"Nin","year":"2021","journal-title":"Cell Rep"},{"key":"B69","article-title":"Overexpression of MAGE\/GAGE genes in paclitaxel\/doxorubicin-resistant human cancer cell lines","volume":"9","author":"Duan","year":"2003","journal-title":"Clin Cancer Res"},{"key":"B70","article-title":"5-aza-2'-deoxycytidine-induced expression of functional cancer testis antigens in human renal cell carcinoma: immunotherapeutic implications","volume":"8","author":"Coral","year":"2002","journal-title":"Clin Cancer Res"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-01-693572","article-title":"p21-activated kinase 2 regulates HSPC cytoskeleton, migration, and homing via CDC42 activation and interaction with \u03b2-Pix","volume":"127","author":"Reddy","year":"2016","journal-title":"Blood"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.30175","article-title":"PAK1 and PAK2 in cell metabolism regulation","volume":"123","author":"Ko\u0159\u00e1nov\u00e1","year":"2022","journal-title":"J Cell Biochem"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.7150\/thno.46137","article-title":"CDK12 and PAK2 as novel therapeutic targets for human gastric cancer","volume":"10","author":"Liu","year":"2020","journal-title":"Theranostics"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02524-2","article-title":"Development and validation of a small extracellular vesicle-derived RNA signature for early diagnosis of lung adenocarcinoma and prognosis in advanced stages","author":"Meng","year":"2025","journal-title":"Mol Cancer"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1002\/1878-0261.13625","article-title":"Kinase activities in pancreatic ductal adenocarcinoma with prognostic and therapeutic avenues","volume":"18","author":"Vall\u00e9s-Mart\u00ed","year":"2024","journal-title":"Mol Oncol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1347683","article-title":"Molecular mechanisms of pancreatic cancer liver metastasis: the role of PAK2","volume":"15","author":"Yang","year":"2024","journal-title":"Front Immunol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.7573","article-title":"Oncogenic epithelial cell-derived exosomes containing Rac1 and PAK2 induce angiogenesis in recipient endothelial cells","volume":"7","author":"Gopal","year":"2016","journal-title":"Oncotarget"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-017-0086-y","article-title":"Pyruvate kinase M2 promotes pancreatic ductal adenocarcinoma invasion and metastasis through phosphorylation and stabilization of PAK2 protein","volume":"37","author":"Cheng","year":"2018","journal-title":"Oncogene"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.17304","article-title":"LncRNA FAF attenuates hypoxia\/ischaemia-induced pyroptosis via the miR-185-5p\/PAK2 axis in cardiomyocytes","volume":"26","author":"Gu","year":"2022","journal-title":"J Cell Mol Med"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-006-0137-x","article-title":"Identification and characterization of HLA-class-I-restricted T-cell epitopes in the putative tumor-associated antigens P21-activated serin kinase 2 (PAK2) and cyclin-dependent kinase inhibitor 1A (CDKN1A)","volume":"85","author":"Li","year":"2006","journal-title":"Ann Hematol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.172.12.7324","article-title":"A novel role for p21-activated protein kinase 2 in T cell activation","volume":"172","author":"Chu","year":"2004","journal-title":"J Immunol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.200204155","article-title":"Human TPX2 is required for targeting Aurora-A kinase to the spindle","volume":"158","author":"Kufer","year":"2002","journal-title":"J Cell Biol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2024-332782","article-title":"TPX2 serves as a novel target for expanding the utility of PARPi in pancreatic cancer through conferring synthetic lethality","volume":"74","author":"Xiao","year":"2025","journal-title":"Gut"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.453","article-title":"Therapeutic potential of targeting protein for Xklp2 silencing for pancreatic cancer","volume":"4","author":"Miwa","year":"2015","journal-title":"Cancer Med"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1007\/s13402-020-00498-5","article-title":"Aurora A kinase and its activator TPX2 are potential therapeutic targets in KRAS-induced pancreatic cancer","volume":"43","author":"Gomes-Filho","year":"2020","journal-title":"Cell Oncol (Dordr)"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-024-03628-0","article-title":"Exploring the clinical significance of TPX2 in pancreatic cancer: from biomarker to immunotherapy","volume":"398","author":"Zhang","year":"2025","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-09-0077","article-title":"Validation of TPX2 as a potential therapeutic target in pancreatic cancer cells","volume":"15","author":"Warner","year":"2009","journal-title":"Clin Cancer Res"},{"key":"B88","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41419-022-04645-8","article-title":"Downregulation of TPX2 impairs the antitumor activity of CD8+ T cells in hepatocellular carcinoma","volume":"13","author":"Wang","year":"2022","journal-title":"Cell Death Dis"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2008.08.001","article-title":"The ADAM metalloproteinases","volume":"29","author":"Edwards","year":"2008","journal-title":"Mol Aspects Med"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-018-2796-x","article-title":"The pleiotropic roles of ADAM9 in the biology of solid tumors","volume":"75","author":"Oria","year":"2018","journal-title":"Cell Mol Life Sci"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6601645","article-title":"ADAM9 expression in pancreatic cancer is associated with tumour type and is a prognostic factor in ductal adenocarcinoma","volume":"90","author":"Gr\u00fctzmann","year":"2004","journal-title":"Br J Cancer"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-023-00720-x","article-title":"Inhibition of ADAM9 promotes the selective degradation of KRAS and sensitizes pancreatic cancers to chemotherapy","volume":"5","author":"Huang","year":"2024","journal-title":"Nat Cancer"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1080\/21691401.2019.1671856","article-title":"Circular RNA ADAM9 facilitates the Malignant behaviours of pancreatic cancer by sponging miR-217 and upregulating PRSS3 expression","volume":"47","author":"Xing","year":"2019","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1158\/1541-7786.Mcr-11-0272","article-title":"MiR-126 acts as a tumor suppressor in pancreatic cancer cells via the regulation of ADAM9","volume":"10","author":"Hamada","year":"2012","journal-title":"Mol Cancer Res"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-16-2609","article-title":"miRNA-520f reverses epithelial-to-mesenchymal transition by targeting ADAM9 and TGFBR2","volume":"77","author":"van Kampen","year":"2017","journal-title":"Cancer Res"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-16-1898","article-title":"KRAS\/NF-\u03baB\/YY1\/miR-489 signaling axis controls pancreatic cancer metastasis","volume":"77","author":"Yuan","year":"2017","journal-title":"Cancer Res"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1002\/1878-0261.12426","article-title":"ADAM9 contributes to vascular invasion in pancreatic ductal adenocarcinoma","volume":"13","author":"Oria","year":"2019","journal-title":"Mol Oncol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1007\/s00251-022-01292-3","article-title":"Unfavorable immunotherapy plus tyrosine kinase inhibition outcome of metastatic renal cell carcinoma after radical nephrectomy with increased ADAM9 expression","volume":"75","author":"Xu","year":"2023","journal-title":"Immunogenetics"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1586\/era.12.67","article-title":"Loss of miR-126 is crucial to pancreatic cancer progression","volume":"12","author":"Frampton","year":"2012","journal-title":"Expert Rev Anticancer Ther"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.110556","article-title":"Recent advances of the Ephrin and Eph family in cardiovascular development and pathologies","volume":"27","author":"Zhu","year":"2024","journal-title":"iScience"},{"key":"B101","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s10456-016-9514-9","article-title":"EphrinB2\/EphB4 pathway in postnatal angiogenesis: a potential therapeutic target for ischemic cardiovascular disease","volume":"19","author":"Yang","year":"2016","journal-title":"Angiogenesis"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.3390\/genes15121545","article-title":"Upregulation of ABLIM1 differentiates intrahepatic cholangiocarcinoma from hepatocellular carcinoma and both colorectal and pancreatic adenocarcinoma liver metastases","volume":"15","author":"Dra\u0161kovi\u010d","year":"2024","journal-title":"Genes (Basel)"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.7150\/thno.76232","article-title":"Elevated ITGA5 facilitates hyperactivated mTORC1-mediated progression of laryngeal squamous cell carcinoma via upregulation of EFNB2","volume":"12","author":"Li","year":"2022","journal-title":"Theranostics"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2025.5821","article-title":"Ephrin-B2 promotes gastric cancer growth by inhibiting apoptosis and regulating the cell cycle via the Wnt\/\u03b2-catenin signaling pathway","volume":"68","author":"Ding","year":"2026","journal-title":"Int J Oncol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.4238\/2015.August.28.14","article-title":"Integrated microRNA-mRNA analysis of pancreatic ductal adenocarcinoma","volume":"14","author":"Liu","year":"2015","journal-title":"Genet Mol Res"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.109972","article-title":"EFNB2 facilitates cell proliferation, migration, and invasion in pancreatic ductal adenocarcinoma via the p53\/p21 pathway and EMT","volume":"125","author":"Zhu","year":"2020","journal-title":"BioMed Pharmacother"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-20-3892","article-title":"Induction of ADAM10 by radiation therapy drives fibrosis, resistance, and epithelial-to-mesenchyal transition in pancreatic cancer","volume":"81","author":"Mueller","year":"2021","journal-title":"Cancer Res"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-025-01921-7","article-title":"Multi-omics unravel heterogeneity of glucose metabolism reprogramming in gastric cancer","volume":"26","author":"Liang","year":"2025","journal-title":"Clin Exp Med"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.171.1.106","article-title":"Ephrin B2 induces T cell costimulation","volume":"171","author":"Yu","year":"2003","journal-title":"J Immunol"},{"key":"B110","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s13148-018-0533-9","article-title":"Histone demethylase JARID1B\/KDM5B promotes aggressiveness of non-small cell lung cancer and serves as a good prognostic predictor","volume":"10","author":"Kuo","year":"2018","journal-title":"Clin Epigenet"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2014.02.004","article-title":"Histone demethylase RBP2 is critical for breast cancer progression and metastasis","volume":"6","author":"Cao","year":"2014","journal-title":"Cell Rep"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1600420113","article-title":"Resistance to docetaxel in prostate cancer is associated with androgen receptor activation and loss of KDM5D expression","volume":"113","author":"Komura","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.887385","article-title":"Expression, prognostic value, and functional mechanism of the KDM5 family in pancreatic cancer","volume":"10","author":"Duan","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.96134","article-title":"Multiple comprehensive analyses identify lysine demethylase KDM as a potential therapeutic target for pancreatic cancer","volume":"21","author":"Shen","year":"2024","journal-title":"Int J Med Sci"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-021-01016-6","article-title":"Hypoxia promotes the metastasis of pancreatic cancer through regulating NOX4\/KDM5A-mediated histone methylation modification changes in a HIF1A-independent manner","volume":"13","author":"Li","year":"2021","journal-title":"Clin Epigenet"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.Mcr-14-0457","article-title":"Dynamic epigenetic regulation by menin during pancreatic islet tumor formation","volume":"13","author":"Lin","year":"2015","journal-title":"Mol Cancer Res"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102975","article-title":"Epigenetically upregulated NSUN2 confers ferroptosis resistance in endometrial cancer via m(5)C modification of SLC7A11 mRNA","volume":"69","author":"Chen","year":"2024","journal-title":"Redox Biol"},{"key":"B118","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.canlet.2021.03.013","article-title":"Mitochondrial pyruvate carrier 1 regulates ferroptosis in drug-tolerant persister head and neck cancer cells via epithelial-mesenchymal transition","volume":"507","author":"You","year":"2021","journal-title":"Cancer Lett"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aax2282","article-title":"Enhancing KDM5A and TLR activity improves the response to immune checkpoint blockade","volume":"12","author":"Wang","year":"2020","journal-title":"Sci Transl Med"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2025-336541","article-title":"NSUN6 deficiency drives immune suppression in pancreatic cancer via the KDM5A-CCL2-macrophage axis","author":"Zeng","year":"2026","journal-title":"Gut"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.Cir-22-0088","article-title":"KDM5A inhibits antitumor immune responses through downregulation of the antigen-presentation pathway in ovarian cancer","volume":"10","author":"Liu","year":"2022","journal-title":"Cancer Immunol Res"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.135","article-title":"Calcium-activated and apoptotic phospholipid scrambling induced by Ano6 can occur independently of Ano6 ion currents","volume":"4","author":"Kmit","year":"2013","journal-title":"Cell Death Dis"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1093\/labmed\/lmae059","article-title":"Identification of biomarkers associated with pathological tumor staging and their utility in the diagnosis and prognosis of prostate cancer","volume":"56","author":"Xu","year":"2025","journal-title":"Lab Med"},{"key":"B124","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12905-024-02881-y","article-title":"An immune-related exosome signature predicts the prognosis and immunotherapy response in ovarian cancer","volume":"24","author":"Zhu","year":"2024","journal-title":"BMC Womens Health"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1007\/s12031-022-02087-7","article-title":"Identification of key genes associated with risk and prognosis of neuroblastoma","volume":"72","author":"Zhang","year":"2022","journal-title":"J Mol Neurosci"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2018.8962","article-title":"CCR7 regulates ANO6 to promote migration of pancreatic ductal adenocarcinoma cells via the ERK signaling pathway","volume":"16","author":"Wang","year":"2018","journal-title":"Oncol Lett"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.14670\/hh-18-469","article-title":"Significance of anoctamin 6 in progression and prognostic prediction of gastric adenocarcinoma","volume":"37","author":"Li","year":"2022","journal-title":"Histol Histopathol"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1101\/2023.09.15.557802","article-title":"Trogocytosis of cancer-associated fibroblasts promotes pancreatic cancer growth and immune suppression via phospholipid scramblase anoctamin 6 (ANO6)","author":"Ogier","year":"2023","journal-title":"bioRxiv"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.2147\/ott.S211725","article-title":"ANO6 promotes cell proliferation and invasion in glioma through regulating the ERK signaling pathway","volume":"12","author":"Xuan","year":"2019","journal-title":"Onco Targets Ther"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2513910122","article-title":"TMEM16F phospholipid scramblase regulates tumorigenesis by modulating the tumor immune microenvironment","volume":"122","author":"Wu","year":"2025","journal-title":"Proc Natl Acad Sci USA"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-016-2208-z","article-title":"Ion channels in regulated cell death","volume":"73","author":"Kunzelmann","year":"2016","journal-title":"Cell Mol Life Sci"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1007\/s00424-017-2065-0","article-title":"CFTR supports cell death through ROS-dependent activation of TMEM16F (anoctamin 6)","volume":"470","author":"Sim\u00f5es","year":"2018","journal-title":"Pflugers Arch"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20160612","article-title":"Scramblase TMEM16F terminates T cell receptor signaling to restrict T cell exhaustion","volume":"213","author":"Hu","year":"2016","journal-title":"J Exp Med"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.abb5146","article-title":"TMEM16F mediates bystander TCR-CD3 membrane dissociation at the immunological synapse and potentiates T cell activation","volume":"14","author":"Connolly","year":"2021","journal-title":"Sci Signal"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(92)90306-w","article-title":"The small GTPase rab5 functions as a regulatory factor in the early endocytic pathway","volume":"70","author":"Bucci","year":"1992","journal-title":"Cell"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2017.7214","article-title":"Rab5a is overexpressed in oral cancer and promotes invasion through ERK\/MMP signaling","volume":"16","author":"Zhang","year":"2017","journal-title":"Mol Med Rep"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2023.110922","article-title":"NAA20 recruits Rin2 and promotes triple-negative breast cancer progression by regulating Rab5A-mediated activation of EGFR signaling","volume":"112","author":"Qiao","year":"2023","journal-title":"Cell Signal"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2016.05.044","article-title":"Increased expression of Rab5A predicts metastasis and poor prognosis in colorectal cancer patients","volume":"8","author":"Yu","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12518","article-title":"Integrin \u03b16-containing extracellular vesicles promote lymphatic remodelling for pre-metastatic niche formation in lymph nodes via interplay with CD151","volume":"13","author":"Lin","year":"2024","journal-title":"J Extracell Vesicles"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2020.12.022","article-title":"RAB5A promotes the formation of filopodia in pancreatic cancer cells via the activation of cdc42 and \u03b21-integrin","volume":"535","author":"Yuan","year":"2021","journal-title":"Biochem Biophys Res Commun"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-017-2098-y","article-title":"Expression of Rab5a correlates with tumor progression in pancreatic carcinoma","volume":"470","author":"Li","year":"2017","journal-title":"Virchows Arch"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2017.08.157","article-title":"Modulation of RAB5A early endosome trafficking in response to KRas mediated macropinocytic fluxes in pancreatic cancer cells","volume":"493","author":"Teske","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1038\/emboj.2011.387","article-title":"Autophagy regulation by miRNAs: when cleaning goes out of service","volume":"30","author":"Cecconi","year":"2011","journal-title":"EMBO J"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2019.01.109","article-title":"SNHG14 enhances gemcitabine resistance by sponging miR-101 to stimulate cell autophagy in pancreatic cancer","volume":"510","author":"Zhang","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12102731","article-title":"Molecular pathogenesis of pancreatic ductal adenocarcinoma: impact of miR-30c-5p and miR-30c-2-3p regulation on oncogenic genes","volume":"12","author":"Tanaka","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1080\/21655979.2021.1934243","article-title":"The expression and clinical prognostic value of protein phosphatase 1 catalytic subunit beta in pancreatic cancer","volume":"12","author":"Hu","year":"2021","journal-title":"Bioengineered"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.2174\/1386207326666230810142646","article-title":"Clinicopathological characteristics, prognosis, and correlated tumor cell function of tropomodulin-3 in pancreatic adenocarcinoma","volume":"27","author":"Zhong","year":"2024","journal-title":"Comb Chem High Throughput Screen"},{"key":"B148","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1186\/s12967-024-06003-y","article-title":"YWHAG promotes bladder cancer metastasis by regulating TMOD3 to activate ERK1\/2 and JNK phosphorylation in the MAPK pathway","volume":"22","author":"Tian","year":"2024","journal-title":"J Transl Med"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.3892\/or.2019.7052","article-title":"Tropomodulin 3 promotes liver cancer progression by activating the MAPK\/ERK signaling pathway","volume":"41","author":"Jin","year":"2019","journal-title":"Oncol Rep"},{"key":"B150","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.cub.2019.12.049","article-title":"Tropomodulins control the balance between protrusive and contractile structures by stabilizing actin-tropomyosin filaments","volume":"30","author":"Kumari","year":"2020","journal-title":"Curr Biol"},{"key":"B151","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/s13046-022-02451-w","article-title":"Correction: Cleavage of tropomodulin-3 by asparagine endopeptidase promotes cancer Malignancy by actin remodeling and SND1\/RhoA signaling","volume":"41","author":"Chen","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2024.101171","article-title":"TMOD3 accelerated resistance to immunotherapy in KRAS-mutated pancreatic cancer through promoting autophagy-dependent degradation of ASCL4","volume":"78","author":"He","year":"2025","journal-title":"Drug Resist Update"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1016\/j.plipres.2013.06.004","article-title":"Oxysterol-binding proteins: sterol and phosphoinositide sensors coordinating transport, signaling and metabolism","volume":"52","author":"Olkkonen","year":"2013","journal-title":"Prog Lipid Res"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9111601","article-title":"Potential prognostic biomarkers of OSBPL family genes in patients with pancreatic ductal adenocarcinoma","volume":"9","author":"Chou","year":"2021","journal-title":"Biomedicines"},{"key":"B155","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/s12885-023-10713-9","article-title":"The expression, immune infiltration, prognosis, and experimental validation of OSBPL family genes in liver cancer","volume":"23","author":"Tian","year":"2023","journal-title":"BMC Cancer"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13092132","article-title":"Identification of key biomarkers related to lipid metabolism in acute pancreatitis and their regulatory mechanisms based on bioinformatics and machine learning","volume":"13","author":"Zhang","year":"2025","journal-title":"Biomedicines"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.62347\/idxm4018","article-title":"A prognostic metabolism-related gene signature associated with the tumor immune microenvironment in neuroblastoma","volume":"14","author":"Yu","year":"2024","journal-title":"Am J Cancer Res"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1186\/s41065-025-00413-8","article-title":"Construction of a ferroptosis-based prediction model for the prognosis of MYCN-amplified neuroblastoma and screening and verification of target sites","volume":"162","author":"Tan","year":"2025","journal-title":"Hereditas"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1042\/bst0340389","article-title":"The OSBP-related proteins (ORPs): global sterol sensors for co-ordination of cellular lipid metabolism, membrane trafficking and signalling processes","volume":"34","author":"Olkkonen","year":"2006","journal-title":"Biochem Soc Trans"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1097472","article-title":"Identification of tumor antigens and immune landscapes for bladder urothelial carcinoma mRNA vaccine","volume":"14","author":"Sun","year":"2023","journal-title":"Front Immunol"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2017.115","article-title":"Extended RAS analysis and correlation with overall survival in advanced pancreatic cancer","volume":"116","author":"Haas","year":"2017","journal-title":"Br J Cancer"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1007\/s12253-017-0341-0","article-title":"Clinical implications of NRAS overexpression in resectable pancreatic adenocarcinoma patients","volume":"25","author":"Martinez-Useros","year":"2019","journal-title":"Pathol Oncol Res"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1101\/gad.352081.124","article-title":"Undruggable KRAS\": druggable after all","volume":"39","author":"Cox","year":"2025","journal-title":"Genes Dev"},{"key":"B164","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s43018-023-00653-5","article-title":"Imetelstat-mediated alterations in fatty acid metabolism to induce ferroptosis as a therapeutic strategy for acute myeloid leukemia","volume":"5","author":"Bruedigam","year":"2024","journal-title":"Nat Cancer"},{"key":"B165","article-title":"HMGB1 regulates erastin-induced ferroptosis via RAS-JNK\/p38 signaling in HL-60\/NRAS(Q61L) cells","volume":"9","author":"Ye","year":"2019","journal-title":"Am J Cancer Res"},{"key":"B166","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s12672-025-02200-3","article-title":"Revealing the prognostic potential of natural killer cell-related genes in hepatocellular carcinoma: the key role of NRAS","volume":"16","author":"Li","year":"2025","journal-title":"Discov Oncol"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.2174\/156720511795563764","article-title":"Frontotemporal dementia caused by CHMP2B mutations","volume":"8","author":"Isaacs","year":"2011","journal-title":"Curr Alzheimer Res"},{"key":"B168","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1007\/s12672-025-02190-2","article-title":"Identification of autophagy-related immune targets for enhancing immunotherapy in pancreatic cancer aggressiveness","volume":"16","author":"Deng","year":"2025","journal-title":"Discov Oncol"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.5306\/wjco.v15.i2.329","article-title":"Identification and validation of a pyroptosis-related prognostic model for colorectal cancer based on bulk and single-cell RNA sequencing data","volume":"15","author":"Zhu","year":"2024","journal-title":"World J Clin Oncol"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.743938","article-title":"Identification of an autophagy-related pair signature for predicting prognoses and immune activity in pancreatic adenocarcinoma","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Immunol"},{"key":"B171","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s13045-020-00990-3","article-title":"Targeting the Wnt\/\u03b2-catenin signaling pathway in cancer","volume":"13","author":"Zhang","year":"2020","journal-title":"J Hematol Oncol"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.Mcr-08-0039","article-title":"Secreted frizzled-related protein 4 regulates two Wnt7a signaling pathways and inhibits proliferation in endometrial cancer cells","volume":"6","author":"Carmon","year":"2008","journal-title":"Mol Cancer Res"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1038\/s41368-024-00279-y","article-title":"WNT7A promotes tumorigenesis of head and neck squamous cell carcinoma via activating FZD7\/JAK1\/STAT3 signaling","volume":"16","author":"Huang","year":"2024","journal-title":"Int J Oral Sci"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA118.001689","article-title":"Wnt7a activates canonical Wnt signaling, promotes bladder cancer cell invasion, and is suppressed by miR-370-3p","volume":"293","author":"Huang","year":"2018","journal-title":"J Biol Chem"},{"key":"B175","doi-asserted-by":"publisher","first-page":"15792","DOI":"10.1038\/s41598-018-34094-3","article-title":"High expression of WNT7A predicts poor prognosis and promote tumor metastasis in pancreatic ductal adenocarcinoma","volume":"8","author":"Wu","year":"2018","journal-title":"Sci Rep"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.7150\/jca.69617","article-title":"CAV2 regulates Mir-4723\/Wnt7A signalling axis through endocytosis and epithelial-mesenchymal transition to promote proliferation, invasion, and metastasis of pancreatic cancer cells","volume":"13","author":"Li","year":"2022","journal-title":"J Cancer"},{"key":"B177","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12943-025-02262-5","article-title":"EIF4E-mediated biogenesis of circPHF14 promotes the growth and metastasis of pancreatic ductal adenocarcinoma via Wnt\/\u03b2-catenin pathway","volume":"24","author":"Fang","year":"2025","journal-title":"Mol Cancer"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2006.02694.x","article-title":"Mutational analyses of WNT7A and HDAC11 as candidate tumour suppressor genes in sporadic Malignant pancreatic endocrine tumours","volume":"66","author":"Lindberg","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.Cir-24-0484","article-title":"Blocking WNT7A enhances MHC-I antigen presentation and enhances the effectiveness of immune checkpoint blockade therapy","volume":"13","author":"Sun","year":"2025","journal-title":"Cancer Immunol Res"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2025.e42794","article-title":"Overexpressed Wnt-7a acts as a potential antitumor immune modulator and predicts poor prognosis in HNSCC","volume":"11","author":"Jiang","year":"2025","journal-title":"Heliyon"},{"key":"B181","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13046-023-02920-w","article-title":"TrkA promotes MDM2-mediated AGPS ubiquitination and degradation to trigger prostate cancer progression","volume":"43","author":"Zhang","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"key":"B182","doi-asserted-by":"publisher","first-page":"7184","DOI":"10.1038\/s41467-024-51489-1","article-title":"The lipid-metabolism enzyme ECI2 reduces neutrophil extracellular traps formation for colorectal cancer suppression","volume":"15","author":"Chen","year":"2024","journal-title":"Nat Commun"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1310894110","article-title":"Ether lipid generating enzyme AGPS alters the balance of structural and signaling lipids to fuel cancer pathogenicity","volume":"110","author":"Benjamin","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"B184","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cell.2009.11.027","article-title":"Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis","volume":"140","author":"Nomura","year":"2010","journal-title":"Cell"},{"key":"B185","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1038\/s41467-023-37924-9","article-title":"Ether phospholipids are required for mitochondrial reactive oxygen species homeostasis","volume":"14","author":"Chen","year":"2023","journal-title":"Nat Commun"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-024-01167-5","article-title":"Helicobacter pylori CagA-mediated ether lipid biosynthesis promotes ferroptosis susceptibility in gastric cancer","volume":"56","author":"Peng","year":"2024","journal-title":"Exp Mol Med"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.116811","article-title":"PDX1 phosphorylation at S61 by mTORC1 links nutrient signaling to \u03b2 cell function and metabolic disease","volume":"45","author":"Fan","year":"2026","journal-title":"Cell Rep"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2026.1771707","article-title":"Molecular mechanisms underlying the lifespan and healthspan benefits of dietary restriction across species","volume":"17","author":"Fan","year":"2026","journal-title":"Front Genet"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.3390\/cells13090781","article-title":"Nuclear mTOR signaling orchestrates transcriptional programs underlying cellular growth and metabolism","volume":"13","author":"Zhao","year":"2024","journal-title":"Cells"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcb.2022.151240","article-title":"Amino acids control blood glucose levels through mTOR signaling","volume":"101","author":"Fan","year":"2022","journal-title":"Eur J Cell Biol"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.3390\/muscles4030026","article-title":"Mechanisms underlying muscle-related diseases and aging: insights into pathophysiology and therapeutic strategies","volume":"4","author":"Fan","year":"2025","journal-title":"Muscles"},{"key":"B192","doi-asserted-by":"publisher","first-page":"4077","DOI":"10.1038\/s41467-021-24331-1","article-title":"Microbial short-chain fatty acids modulate CD8(+) T cell responses and improve adoptive immunotherapy for cancer","volume":"12","author":"Luu","year":"2021","journal-title":"Nat Commun"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1038\/ncb2873","article-title":"Somatic cells regulate maternal mRNA translation and developmental competence of mouse oocytes","volume":"15","author":"Chen","year":"2013","journal-title":"Nat Cell Biol"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.137460","article-title":"A highly branched glucomannan from the fruiting body of Schizophyllum commune: structural characteristics and antitumor properties analysis","volume":"282","author":"Gao","year":"2024","journal-title":"Int J Biol Macromol"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2025.13784","article-title":"Melatonin induces autophagy in neuroblastoma by alleviating Pak2-mediated endoplasmic reticulum stress","volume":"33","author":"Qiu","year":"2026","journal-title":"Mol Med Rep"},{"key":"B196","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/ijc.1307","article-title":"MAGE, BAGE and GAGE gene expression in human rhabdomyosarcomas","volume":"93","author":"Dalerba","year":"2001","journal-title":"Int J Cancer"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-03-0640","article-title":"Identification of C-met oncogene as a broadly expressed tumor-associated antigen recognized by cytotoxic T-lymphocytes","volume":"10","author":"Schag","year":"2004","journal-title":"Clin Cancer Res"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.2147\/ott.S61442","article-title":"HCA519\/TPX2: a potential T-cell tumor-associated antigen for human hepatocellular carcinoma","volume":"7","author":"Aref","year":"2014","journal-title":"Onco Targets Ther"},{"key":"B199","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1126\/science.aaa4971","article-title":"Neoantigens in cancer immunotherapy","volume":"348","author":"Schumacher","year":"2015","journal-title":"Science"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1803792\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T05:39:09Z","timestamp":1777354749000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1803792\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":199,"alternative-id":["10.3389\/fimmu.2026.1803792"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1803792","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,28]]},"article-number":"1803792"}}